Puma Biotechnology, Inc.
(NASDAQ : PBYI)

( )
PBYI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.01%90.691.3%$836.99m
AMGNAmgen Inc.
0.89%188.341.2%$659.06m
GILDGilead Sciences, Inc.
1.84%67.590.9%$528.28m
BIIBBiogen Inc.
2.51%332.871.3%$459.94m
ILMNIllumina, Inc.
2.51%299.823.5%$326.05m
REGNRegeneron Pharmaceuticals, Inc.
2.17%423.972.6%$322.32m
VRTXVertex Pharmaceuticals Incorporated
1.27%188.071.9%$269.19m
ALXNAlexion Pharmaceuticals, Inc.
2.77%129.422.0%$243.58m
AAgilent Technologies, Inc.
1.64%78.281.6%$138.30m
INCYIncyte Corporation
0.88%84.152.5%$117.93m
ALNYAlnylam Pharmaceuticals, Inc
0.60%83.539.2%$73.46m
SGENSeattle Genetics, Inc.
4.24%71.486.6%$70.53m
BLUEBluebird Bio, Inc.
2.04%137.0314.4%$66.91m
NKTRNektar Therapeutics
-2.18%41.695.5%$59.28m
MGNXMacroGenics, Inc.
3.41%21.847.2%$57.08m

Company Profile

Puma Biotechnology, Inc. is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Puma Biotechnology was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.